INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Dr Reddys Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500124	ISIN Demat INE089A01031	Book Value 322.46	NSE Symbol DRREDDY	Dividend Yield (%) 0.67	Market Cap (₹ Cr.) 98,962.23	P/E 19.09	EPS 62.12	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	19,483.80	16,962.50	14,405.20	13,349.10	11,850.40
Sale of Products	19,325.30	16,338.00	13,921.20	13,236.40	11,023.10
Sale of Services	127.70	600.20	428.90	72.00	810.50
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	30.80	24.30	55.10	40.70	16.80
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	19,483.80	16,962.50	14,405.20	13,349.10	11,850.40
Other Income	862.30	591.30	482.00	801.10	743.20
Total Revenue	20,346.10	17,553.80	14,887.20	14,150.20	12,593.60
Changes in Inventories	-238.80	129.50	-389.60	-395.60	-99.90
Cost of Material Consumed	3,291.50	3,161.40	3,378.40	3,266.30	2,556.50
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	1,986.60	1,779.30	2,057.10	1,252.30	1,117.20
Employee Benefits	3,085.70	2,832.60	2,434.60	2,270.10	2,030.20
Total Other Expenses	5,432.40	4,844.90	4,330.60	3,819.20	3,376.80
Manufacturing / Operating Expenses	2,010.40	1,656.00	1,365.70	1,244.30	1,104.90
Administrative and Selling Expenses	3,064.60	2,782.80	2,672.90	2,274.90	2,026.80
Other Expenses	357.40	406.10	292.00	300.00	245.10
Finance Costs	21.80	16.90	38.00	46.70	47.80
Depreciation and Amortization	975.60	923.20	814.30	835.00	789.20
Total Expenses	14,554.80	13,687.80	12,663.40	11,094.00	9,817.80
Profit Before Exceptional Items and Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Taxation	1,449.30	1,253.20	600.60	869.80	-161.90
Current Tax	1,361.80	864.10	392.60	540.10	483.90
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	87.50	389.10	208.00	329.70	-645.80
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Earning Per Share - Basic	260.95	157.37	97.85	131.84	177.23
Earning Per Share - Diluted	260.46	157.03	97.58	131.46	176.88
Operation Profit before Depreciation	6,788.70	4,806.10	3,076.10	3,937.90	3,612.80
Operating Profit after Depreciation	5,813.10	3,882.90	2,261.80	3,102.90	2,823.60
Dividend Per Share	40.00	40.00	30.00	25.00	25.00
Dividend Percentage	800.00	800.00	600.00	500.00	500.00
Equity Dividend	667.30	666.11	499.28	415.75	415.43
Weighted Average Shares - Basic	16.64	16.60	16.59	16.58	16.58
Weighted Average Shares - Diluted	16.67	16.64	16.63	16.63	16.61